ZOARIQA

Serial Number 79429071
686

Registration Progress

Application Filed
Jun 6, 2025
Under Examination
Approved for Publication
Oct 7, 2025
Published for Opposition
Oct 7, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Nov 06, 2025 1 days

Trademark Image

ZOARIQA

Basic Information

Serial Number
79429071
Filing Date
June 6, 2025
Published for Opposition
October 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Oct 7, 2025
Application
Pending
Classes
005

Rights Holder

NOVARTIS AG

25
Address
CH-4002 Basel
CH

Ownership History

NOVARTIS AG

Original Applicant
25
CH

NOVARTIS AG

Owner at Publication
25
CH

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
1 days remaining
Published for Opposition
Due Date
November 06, 2025
Extension Available
Until December 06, 2025

Application History

14 events
Date Code Type Description Documents
Oct 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 7, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 4, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 30, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 30, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Aug 30, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 30, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 27, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Aug 8, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 8, 2025 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Jul 31, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification

International Classes
005